United Therapeutics Corporation (UTHR) Operating income 2016–2025
United Therapeutics Corporation (UTHR) annual operating income history from SEC filings — each fiscal year as reported.
$1.5BFY2025 · since FY2016: $1.1B → $1.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.5B | +8.4% |
| FY2024 | $1.4B | +16.2% |
| FY2023 | $1.2B | +20.9% |
| FY2022 | $979.7M | +76.2% |
| FY2021 | $555.9M | -6.4% |
| FY2020 | $593.6M | +416.4% |
| FY2019 | -$187.6M | -123.3% |
| FY2018 | $805.4M | -1.2% |
| FY2017 | $814.9M | -23.2% |
| FY2016 | $1.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice